Latest News and Press Releases

MELBOURNE, AUSTRALIA--(Marketwired - Oct 31, 2013) - -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) Record number of BREVAGen™ samples received...

MELBOURNE, AUSTRALIA--(Marketwired - Oct 15, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) wishes to inform the Market that Chief Executive Officer, Ms. Alison Mew, will be...

MELBOURNE, AUSTRALIA--(Marketwired - Oct 1, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced that a further record number of BREVAGen™ test samples were received...

MELBOURNE, AUSTRALIA--(Marketwired - Sep 26, 2013) - As foreshadowed in its ASX announcement dated 10 July 2013, Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to report that...

SOUTH SAN FRANCISCO, CA--(Marketwired - Sep 23, 2013) - Achaogen, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol...

SAN FRANCISCO, CA--(Marketwired - Sep 9, 2013) - Dear members of the Board and fellow shareholders of Astex Pharmaceuticals, We are the Managing General Partner and Portfolio...

MELBOURNE, AUSTRALIA--(Marketwired - Aug 30, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that it has received its Clinical Laboratory Permit from the New...

BRISBANE, AUSTRALIA--(Marketwired - Aug 20, 2013) - A$3.9m profit share for quarter ending 30 June 2013 Total Alchemia fondaparinux profit share of A$9.6m...

SAN DIEGO, CA--(Marketwired - Aug 5, 2013) -  Vital Therapies®, Inc., a biopharmaceutical company focused on developing a cell-based therapy targeting the treatment of acute liver failure,...

MELBOURNE, AUSTRALIA--(Marketwired - Aug 1, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) Finalised private placement of shares to domestic and...